Nitromethane encephalopathy MRI.
Fernández
Elena Alventosa
EA
elena.alventosa@gmail.com
González
Candelaria González
CG
Pardillo
Javier Crisóstomo
JC
García
Vicente Martín
VM
D000293:Adolescent; D000927:Anticonvulsants / Q000627:therapeutic use; D001921:Brain / Q000187:drug effects* / Q000473:pathology* / Q000503:physiopathology; D002526:Cerebellar Diseases / Q000139:chemically induced / Q000473:pathology / Q000503:physiopathology; D002531:Cerebellum / Q000187:drug effects / Q000473:pathology / Q000503:physiopathology; D004830:Epilepsy, Tonic-Clonic / Q000139:chemically induced / Q000473:pathology / Q000503:physiopathology; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008697:Methane / Q000031:analogs & derivatives* / Q000506:poisoning; D009413:Nerve Fibers, Myelinated / Q000187:drug effects / Q000473:pathology; D020258:Neurotoxicity Syndromes / Q000209:etiology* / Q000473:pathology* / Q000503:physiopathology; D009595:Nitroparaffins / Q000506:poisoning*; D020127:Recovery of Function; D013226:Status Epilepticus / Q000139:chemically induced / Q000473:pathology / Q000503:physiopathology; D003336:Tectum Mesencephali / Q000187:drug effects / Q000473:pathology / Q000503:physiopathology; D013995:Time; D016896:Treatment Outcome; D014635:Valproic Acid / Q000627:therapeutic use
D000927:Anticonvulsants; D009595:Nitroparaffins; D014635:Valproic Acid; D008697:Methane; C008640:nitromethane